Abstract

The blood–brain barrier (BBB) plays a vital role in maintaining the specialized microenvironment of the neural tissue. It separates the peripheral circulatory system from the brain parenchyma while facilitating communication. Alterations in the distinct physiological properties of the BBB lead to BBB breakdown associated with normal aging and various neurodegenerative diseases. In this review, we first briefly discuss the aging process, then review the phenotypes and mechanisms of BBB breakdown associated with normal aging that further cause neurodegeneration and cognitive impairments. We also summarize dementia such as Alzheimer's disease (AD) and vascular dementia (VaD) and subsequently discuss the phenotypes and mechanisms of BBB disruption in dementia correlated with cognition decline. Overlaps between AD and VaD are also discussed. Techniques that could identify biomarkers associated with BBB breakdown are briefly summarized. Finally, we concluded that BBB breakdown could be used as an emerging biomarker to assist to diagnose cognitive impairment associated with normal aging and dementia.

Highlights

  • The central nervous system (CNS) comprises the brain and spinal cord that control all the essential functions of the body

  • In Alzheimer’s disease (AD) with disruption of blood–brain barrier (BBB), Aβ and neurofibrillary tangles (NFT) of p-tau accumulate in the blood vessel, causing further inflammation in the neurovascular unit (NVU) that, in turn, induces the release inflammatory factors to degenerate neurons associated with a decline in cognition

  • Another factor that degrades the integrity of BBB associated with AD is APOE4

Read more

Summary

Introduction

The central nervous system (CNS) comprises the brain and spinal cord that control all the essential functions of the body. In the aged human brain, the level of soluble PDGFRβ in cerebrospinal fluid (CSF) increases, showing damage to the pericyte associated with BBB disruption (Montagne et al, 2015; Sagare et al, 2015; Nation et al, 2019).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.